Analysis of first-trimester combined test results in preparation for a cell-free fetal DNA era

To survey experience with the first-trimester combined test (FCT) for trisomy 21 (T21) in different risk score groups to determine the most useful clinical application of cell-free fetal DNA (cffDNA) screening.

Source: International Journal of Gynaecology and Obstetrics - August 10, 2016 Category: OBGYN Authors: Semir Kose, Dilek C ımrın, Nuri Yıldırım, Ozge Aksel, Pembe Keskinoglu, Elcin Bora, Tufan Cankaya, Sabahattin Altunyurt Tags: Clinical article Source Type: research